The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial
Open accessAbstract
BACKGROUND & AIMS Exclusive enteral nutrition (EEN) is recommended for children with mild-to-moderate Crohn's disease (CD) but implementation is challenging. We compared EEN to the CD exclusion-diet (CDED), a whole-food diet coupled with partial enteral nutrition (PEN), designed to reduce exposure to dietary components that have adverse effects on the microbiome and intestinal barrier. METHODS We performed a 12-week prospective trial of children with mild to moderate CD. The children were randomly assigned to a group that received CDED plus 50% of calories from formula (Modulen, Nestlé) for 6 weeks (stage 1) followed by CDED with 25% PEN from weeks 7-12 (stage-2) (n=40, group 1) or a group that received EEN for 6 weeks followed by a free diet with 25% PEN from weeks 7-12 (n=38, group 2). Patients were evaluated at baseline and weeks 3, 6, and 12 and laboratory tests were performed. 16S rRNA gene (V4V5) sequencing was performed on stool samples. The primary endpoint was dietary tolerance. Secondary endpoints were intention to treat (ITT) remission at week 6 ( pediatric CD activity index score below 10) and corticosteroid-free ITT sustained remission at week 12. RESULTS Four patients withdrew from the study because of intolerance by 48 hours, 74 patients (mean age 14.2±2.7 years) were included for remission analysis. The combination of CDED and PEN was tolerated in 39 children (97.5%), whereas EEN was tolerated by 28 children (73.6%) (P=.002; odds ratio for tolerance of CDED and PEN, 13.92; 95% CI, 1.68-115.14). At week 6, 30/40 children (75%) given CDED plus PEN were in corticosteroid-free remission vs 20/34 children (59%) given EEN (P=.38). At week 12, 28/37 children (75.6%) given CDED plus PEN were in corticosteroid-free remission compared with 14/31 children (45.1%) given EEN and then PEN (P=.01; odds ratio for remission in children given CDED and PEN, 3.77; CI, 1.34-10.59). In children given CDED plus PEN, corticosteroid-free remission was associated with sustained reductions in inflammation (based on serum level of C-reactive protein and fecal level of calprotectin) and fecal Proteobacteria. CONCLUSION CDED plus PEN was better tolerated than EEN in children with mild to moderate CD. Both diets were effective in inducing remission by week 6. The combination CDED plus PEN induced sustained remission in a significantly higher proportion of patients than EEN, and produced changes in the fecal microbiome associated with remission. These data support use of CDED plus PEN to induce remission in children with CD. Clinicaltrials.gov no: NCT01728870.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Levine, A., Griffiths, A., Markowitz, J., Wilson, D. C., Turner, D., Russell, R. K., Fell, J., Ruemmele, F. M., Walters, T., Sherlock, M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21493 · Cited by 1,512
Self-citationConsensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease
Ruemmele, F. M., Veres, G., Kolho, K. L., Griffiths, A., Levine, A., Escher, J. C., Amil Dias, J., Barabino, A., Braegger, C. P., Bronsky, J., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.04.005 · Cited by 1,083
Lewis, J. D., Chen, E. Z., Baldassano, R. N., Otley, A. R., Griffiths, A. M., Lee, D., Bittinger, K., Bailey, A., Friedman, E. S., Hoffmann, C., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.09.008 · Cited by 823
Microbiome Helper: a Custom and Streamlined Workflow for Microbiome Research
Comeau, A. M., Douglas, G. M., & Langille, M. G. I. (2017) · mSystems · doi:10.1128/msystems.00127-16 · Cited by 679
Kugathasan, S., Denson, L. A., Walters, T. D., Kim, M.-O., Marigorta, U. M., Schirmer, M., Mondal, K., Liu, C., Griffiths, A., Noe, J. D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30317-3 · Cited by 633
Self-citationEnteral nutritional therapy for induction of remission in Crohn's disease
Zachos, M., Tondeur, M., & Griffiths, A. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000542.pub2 · Cited by 598
Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases
Levine, A., Sigall Boneh, R., & Wine, E. (2018) · Gut · doi:10.1136/gutjnl-2017-315866 · Cited by 376
Self-citationSvolos, V., Hansen, R., Nichols, B., Quince, C., Ijaz, U. Z., Papadopoulou, R. T., Edwards, C. A., Watson, D., Alghamdi, A., Brejnrod, A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.002 · Cited by 317
Turner, D., Griffiths, A. M., Walters, T. D., Seah, T., Markowitz, J., Pfefferkorn, M., Keljo, D., Waxman, J., Otley, A., LeLeiko, N. S., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21649 · Cited by 301
Self-citationEnteral nutritional therapy for induction of remission in Crohn's disease
Narula, N., Dhillon, A., Zhang, D., Sherlock, M. E., Tondeur, M., & Zachos, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000542.pub3 · Cited by 301
Sigall-Boneh, R., Pfeffer-Gik, T., Segal, I., Zangen, T., Boaz, M., & Levine, A. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000110 · Cited by 298
Self-citationJohnson, T., Macdonald, S., Hill, S. M., Thomas, A., & Murphy, M. S. (2006) · Gut · doi:10.1136/gut.2004.062554 · Cited by 247
tmle: An R Package for Targeted Maximum Likelihood Estimation
Gruber, S., & Laan, M. J. V. D. (2012) · Journal of Statistical Software · doi:10.18637/jss.v051.i13 · Cited by 211
Sigall Boneh, R., Sarbagili Shabat, C., Yanai, H., Chermesh, I., Ben Avraham, S., Boaz, M., & Levine, A. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx071 · Cited by 205
Self-citationBUCHANAN, E., GAUNT, W. W., CARDIGAN, T., GARRICK, V., MCGROGAN, P., & RUSSELL, R. K. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04067.x · Cited by 173
Lee, D., Baldassano, R. N., Otley, A. R., Albenberg, L., Griffiths, A. M., Compher, C., Chen, E. Z., Li, H., Gilroy, E., Nessel, L., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000426 · Cited by 171
Effects of Enteral Nutrition on Crohn’s Disease: Clues to the Impact of Diet on Disease Pathogenesis
Levine, A., & Wine, E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182802acc · Cited by 107
Self-citationOlén, O., Askling, J., Sachs, M. C., Frumento, P., Neovius, M., Smedby, K. E. E., Ekbom, A., Malmborg, P., & Ludvigsson, J. F. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.028 · Cited by 106
Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohnʼs Disease
Levine, A., Turner, D., Gik, T. P., Dias, J. A., Veres, G., Shaoul, R. R., Staiano, A., Escher, J. C., Kolho, K., Pærregaard, A., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437735.11953.68 · Cited by 92
Self-citationCameron, F., Gerasimidis, K., Papangelou, A., Missiou, D., Garrick, V., Cardigan, T., Buchanan, E., Barclay, A. R., McGrogan, P., & Russell, R. K. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12230 · Cited by 91
Grover, Z., Burgess, C. J., Muir, R., Reilly, C., & Lewindon, P. J. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw075 · Cited by 91
Connors, J., Basseri, S., Grant, A. K., Giffin, N. A., Mahdi, G., Noble, A. J., Rashid, M., Otley, A. R., & Limbergen, J. V. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx060 · Cited by 90
Cohen-Dolev, N., Sładek, M., Hussey, S., Turner, D., Veres, G., Koletzko, S., de Carpi, J. M., Staiano, A., Shaoul, R. R., Lionetti, P., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx150 · Cited by 88
Self-citationFrivolt, K., Schwerd, T., Werkstetter, K. J., Schwarzer, A., Schatz, S. B., Bufler, P., & Koletzko, S. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12770 · Cited by 79
Global Variation in Use of Enteral Nutrition for Pediatric Crohn Disease
Lawley, M., Wu, J., Navas‐López, V. M., Huynh, H. Q., Carroll, M. W., Chen, M., Medvedev, P., Day, A. S., Hussey, S., Boneh, R. S., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001946 · Cited by 65
Self-citationMcOmber, M. E., Ou, C., & Shulman, R. J. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181aa3aa9 · Cited by 58
Grover, Z., & Lewindon, P. J. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3722-9 · Cited by 57
Joosse, M. E., Aardoom, M. A., Kemos, P., Turner, D., Wilson, D. C., Koletzko, S., Martin‐de‐Carpi, J., Fagerberg, U. L., Spray, C., Tzivinikos, C., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14893 · Cited by 54
Self-citationLimbergen, J. V., Haskett, J., Griffiths, A. M., Critch, J., Huynh, H. Q., Ahmed, N., deBruyn, J. C. C., Issenman, R. M., El‐Matary, W., Walters, T. D., et al. (2015) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2015/509497 · Cited by 54
Self-citationUse of Placebo in Pediatric Inflammatory Bowel Diseases
Turner, D., Koletzko, S., Griffiths, A. M., Hyams, J. S., Dubinsky, M. C., de Ridder, L., Escher, J. C., Lionetti, P., Cucchiara, S., Lentze, M. J., et al. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001024 · Cited by 45
tmle : An R Package for Targeted Maximum Likelihood Estimation
Gruber, S., & van der Laan, M. J. (2011) · Collection of Biostatistics Research Archive (COBRA) · Cited by 39
Cited by
The microbiome and inflammatory bowel disease
Glassner, K. L., Abraham, B. P., & Quigley, E. M. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.003 · Cited by 837
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
van Rheenen, P. F., Aloi, M., Assa, A., Bronsky, J., Escher, J. C., Fagerberg, U. L., Gasparetto, M., Gerasimidis, K., Griffiths, A., Henderson, P., et al. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa161 · Cited by 729
Self-citationDolinger, M., Torres, J., & Vermeire, S. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02586-2 · Cited by 580
ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Bischoff, S. C., Bager, P., Escher, J., Forbes, A., Hébuterne, X., Hvas, C. L., Joly, F., Klek, S., Krznaric, Z., Ockenga, J., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2022.12.004 · Cited by 367
The Role of the Gut Microbiota in the Relationship Between Diet and Human Health
Perler, B. K., Friedman, E. S., & Wu, G. D. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031522-092054 · Cited by 362
Metadata
- Authors
- Levine, A., Wine, E., Assa, A., Sigall Boneh, R., Shaoul, R., Kori, M., Cohen, S., Peleg, S., Shamaly, H., On, A., Millman, P., Abramas, L., Ziv-Baran, T., Grant, S., Abitbol, G., Dunn, K. A., Bielawski, J. P., & Van Limbergen, J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 157
- Issue
- 2
- Pages
- 440-450.e8
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2948489634
- Cited by
- 671
- References
- 34
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.